Vilija Oke

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Systemic Lupus Erythematosus

Gas Chromatography

Disease Activity

Top Venues

Arthritis research & therapy

Lupus science & medicine

ACR open rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Aliisa Häyry, Francesca Faustini, Agneta Zickert, Anders Larsson, Timothy B Niewold, Elisabet Svenungsson, Vilija Oke, Iva Gunnarsson
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis. Lupus science & medicine 9 (1) (2022)
Lina-Marcela Diaz-Gallo, Vilija Oke, Emeli Lundström, Kerstin Elvin, Yee Ling Wu, Susanna Eketjäll, Agneta Zickert, Johanna T Gustafsson, Andreas Jönsen, Dag Leonard, Daniel J Birmingham, Gunnel Nordmark, Anders A Bengtsson, Lars Rönnblom, Iva Gunnarsson, Chack-Yung Yu, Leonid Padyukov, Elisabet Svenungsson
Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations. ACR open rheumatology (2021)
Timothy B Niewold, Alexander Meves, Julia S Lehman, Karin Popovic-Silwerfeldt, Aliisa Häyry, Therese Söderlund-Matell, Cristine M Charlesworth, Benjamin Madden, Ingrid E Lundberg, Marie Wahren-Herlenius, Elisabet Svenungsson, Vilija Oke
Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE. Arthritis research & therapy 23 (1) (2021)
Vilija Oke, Iva Gunnarsson, Jessica Dorschner, Susanna Eketjäll, Agneta Zickert, Timothy B Niewold, Elisabet Svenungsson
High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis research & therapy 21 (1) (2019)
Vilija Oke, Susanna Brauner, Anders Larsson, Johanna Gustafsson, Agneta Zickert, Iva Gunnarsson, Elisabet Svenungsson
IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). Arthritis research & therapy 19 (1) (2017)